Aletheia Capital Starts Lam Research (LRCX) at Buy

Aletheia Capital analyst Warren Lau initiates coverage on Lam Research (NASDAQ: LRCX) with a Buy rating and a price target of $260.00.

The analyst comments "We initiate coverage on Lam Research (LRCX) with a Buy and a TP of $260 (30x CY27E/FY28E PER). We anticipate LRCX will sustain its strong growth, underpinned by its industry leading process tools, rising content value, and expanding market share—particularly in AI and HPC applications. Many LRCX’s innovative etching and deposition solutions are purpose‑built to enable advanced 3D architectures such as GAA, BSPD, HBM, CoWoS, SoIC, 4F2 & 3D DRAM and 400+ layers 3D NAND – all critical features for accelerating compute while reducing power – two defining imperatives in AI era. Beyond its core strengths, LRCX’s new wave of technological creations such as dry EUV photoresist and panel-level packaging could further propel LRCX to the next level and further set it apart from peers."

For an analyst ratings summary and ratings history on Lam Research click here. For more ratings news on Lam Research click here.

Shares of Lam Research closed at $194.76 yesterday.

You May Also Be Interested In

• Barclays Starts SK Hynix (SKHY) at Overweight
• H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)
• H.C. Wainwright Reiterates Buy Rating on Aligos Therapeutics Inc. (ALGS)